Q32 Bio (QTTB) Free Cash Flow (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.72% |
| Dec 31, 2025 | -68.82% |
| Sep 30, 2025 | 59.34% |
| Jun 30, 2025 | 18.27% |
| Mar 31, 2025 | -16.77% |
| Dec 31, 2024 | 44.91% |
| Sep 30, 2024 | 11.82% |
| Jun 30, 2024 | -52.99% |
| Mar 31, 2024 | -36.87% |
| Dec 31, 2023 | -166.59% |
| Sep 30, 2023 | 239.23% |
| Jun 30, 2023 | 7.54% |
| Mar 31, 2023 | 54.05% |
| Dec 31, 2022 | -9.10% |
| Sep 30, 2022 | 22.21% |
| Jun 30, 2022 | -4.27% |
| Mar 31, 2022 | -0.35% |
| Dec 31, 2021 | -20.97% |
| Sep 30, 2021 | -8.29% |
| Jun 30, 2021 | 23.67% |
| Mar 31, 2021 | -242.58% |
| Dec 31, 2020 | 69.21% |
| Sep 30, 2020 | 3.84% |
| Jun 30, 2020 | -15.05% |
| Mar 31, 2020 | -0.56% |
| Dec 31, 2019 | -166.91% |
| Sep 30, 2019 | 70.16% |
| Jun 30, 2019 | -41.63% |
| Mar 31, 2019 | 3.60% |
| Dec 31, 2018 | -29.66% |
| Sep 30, 2018 | -33.18% |
| Jun 30, 2018 | -25.59% |
| Mar 31, 2018 | -150.99% |
| Dec 31, 2017 | 413.59% |
| Sep 30, 2017 | -41.48% |
| Jun 30, 2017 | 8.93% |